Thomas P Monath Net Worth & Insider Trades
Thomas P Monath - Director, Novavax Inc
What is Thomas P Monath's Net Worth?
The current estimated net worth of Novavax Inc's Director, Thomas P Monath, is estimated to be about $153.33M . Thomas P Monath owns about 3,225,366 units of Novavax Inc common stock. In the last year at Novavax Inc, Thomas P Monath has sold an estimated value of $0 worth.
What is Thomas P Monath's Past Insider Trading?
In total, Thomas P Monath has made about 3 transactions over a year of their time at Novavax Inc. Thomas P Monath usually trades in March, with the busiest year in 2008. The most recent transaction was a purchase order of 358,803 units , worth over $0 on August 4, 2008.
Thomas Monath
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Thomas P Monath's' Mailing Address?
- Mailing address is 2750 Sand Hill Road Menlo Park CA 94025 CA
Novavax Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
---|---|---|---|---|---|---|---|
Stanley C. Erck Stanley C. Erck | 2020 | $657,181 | $48,086,018 | $44,115,244 | $48,086,018 | $11,400 | $48,086,018 |
Stanley C. Erck Stanley C. Erck | 2019 | $642,720 | $2,438,562 | $986,660 | $2,438,562 | $11,200 | $2,438,562 |
Stanley C. Erck Stanley C. Erck | 2018 | $638,040 | $4,158,398 | $3,509,358 | $4,158,398 | $11,000 | $4,158,398 |
Gregory F. Covino | 2020 | $55,000 | $1,417,774 | $659,967 | $1,417,774 | $8,032 | $1,417,774 |
Gregory F. Covino | 2019 | $― | $― | $― | $― | $― | $― |
Gregory F. Covino | 2018 | $― | $― | $― | $― | $― | $― |
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2020 | $483,443 | $24,923,376 | $22,859,741 | $24,923,376 | $11,400 | $24,923,376 |
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2019 | $470,453 | $1,875,198 | $819,421 | $1,875,198 | $11,200 | $1,875,198 |
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2018 | $460,125 | $1,681,456 | $1,131,189 | $1,681,456 | $11,000 | $1,681,456 |
John J. Trizzino John J. Trizzino | 2020 | $415,892 | $21,327,954 | $19,819,717 | $21,327,954 | $11,400 | $21,327,954 |
John J. Trizzino John J. Trizzino | 2019 | $390,701 | $1,465,602 | $584,103 | $1,465,602 | $9,546 | $1,465,602 |
John J. Trizzino John J. Trizzino | 2018 | $378,078 | $1,329,776 | $890,700 | $1,329,776 | $7,500 | $1,329,776 |
John A. Herrmann III John A. Herrmann III | 2020 | $402,842 | $20,606,814 | $18,924,907 | $20,606,814 | $11,400 | $20,606,814 |
John A. Herrmann III John A. Herrmann III | 2019 | $378,591 | $1,353,416 | $488,397 | $1,353,416 | $11,200 | $1,353,416 |
John A. Herrmann III John A. Herrmann III | 2018 | $362,695 | $1,137,576 | $712,560 | $1,137,576 | $11,000 | $1,137,576 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm
What are Novavax Inc's Past Insider Trades?
Novavax Inc's most recent insider trade came on April 4, 2022 by James Young who sold 12,500 units worth $919.76K . In the last 19 years, insiders at Novavax Inc have sold an estimated value of $286.76M and bought an estimated value of $38.15M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Gregory Glenn, President, Gary Evans, Director, and John A. Herrmann III, EVP .
NOVAVAX INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |